Poolbeg Pharma PLC
POLB
Company Profile
Business description
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.
Contact
42 New Road
Queen Mary BioEnterprises Innovation Centre
LondonE1 2AX
GBRT: +44 2071831499
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
8
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,175.10 | 49.90 | 0.61% |
CAC 40 | 7,543.86 | 41.08 | 0.55% |
DAX 40 | 22,241.33 | 176.82 | 0.80% |
Dow JONES (US) | 40,093.40 | 486.83 | 1.23% |
FTSE 100 | 8,427.66 | 20.22 | 0.24% |
HKSE | 21,980.74 | 70.98 | 0.32% |
NASDAQ | 17,166.04 | 457.99 | 2.74% |
Nikkei 225 | 35,705.74 | 666.59 | 1.90% |
NZX 50 Index | 12,017.84 | 61.37 | 0.51% |
S&P 500 | 5,484.77 | 0.00 | 0.00% |
S&P/ASX 200 | 7,968.20 | 47.70 | 0.60% |
SSE Composite Index | 3,295.06 | 2.23 | -0.07% |